FFNTF (4Front Ventures) Tax Provision : $-6.27 Mil (TTM As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is 4Front Ventures Tax Provision?

4Front Ventures's tax provision for the three months ended in Sep. 2024 was $0.00 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2024 was $-6.27 Mil.

4Front Ventures Tax Provision Historical Data

The historical data trend for 4Front Ventures's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4Front Ventures Tax Provision Chart

4Front Ventures Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

Tax Provision

Get a 7-Day Free Trial

0.04

-15.05

-13.93

-10.08

-7.09

4Front Ventures Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Tax Provision	Get a 7-Day Free Trial															4.20	-6.27	-	-	-

4Front Ventures Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.27 Mil.

4Front Ventures Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » 4Front Ventures Corp (OTCPK:FFNTF) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

FFNT:Canada

Address

7010 E. Chauncey Lane, Suite 235, Phoenix, AZ, USA, 85054

Website

https://www.4frontventures.com

4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to owned dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.

Executives

Leonid Gontmakher	director, officer: Chief Executive Officer	5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
Nicole Frederick	officer: See Remarks	C/O 4FRONT VENTURES CORP., 7010 E. CHAUNCEY LANE STE. 235, PHOENIX AZ 85054
Kristopher Krane	director	5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
David Ryan Daily	director	5060 N 40TH STREET STE 120, PHOENIX AZ 85018
Roman Tkachenko	director	5060 N 40TH STREET STE 120, PHOENIX AZ 85018
Karl Chowscano	other: Consultant	5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
Chetan Gulati	director	28 REICHERT CIRCLE, WESTPORT CT 06880
Keith Edward Adams	officer: Chief Financial Officer	108 S. WETHERLY DRIVE, UNIT 4, LOS ANGELES CA 90048
Robert E Hunt	director	C/O GROWLIFE, INC., 20301 VENTURA BLVD., SUITE 126, WOODLAND HILLS CA 91364
Amit Ramanlal Patel	director	3305 PINE AVENUE, MANHATTAN BEACH CA 90266
Kathi P Lentzsch	director	5060 N 40TH STREET STE 120, PHOENIX AZ 85018
Andrew Thut	officer: Chief Investment Officer	5060 N. 40TH STREET, SUITE 120, PHOENIX AZ 85018
Joseph R Feltham	officer: Chief Operating Officer	5060 N. 40TH STREET, STE 120, PHOENIX AZ 85018
Eric J. Rey	director	ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Nicolle Dorsey	officer: Chief Financial Officer	C/O REAL GOODS SOLAR, INC., 110 16TH STREET, 3RD FLOOR, DENVER CO 80202